The European challenges of funding orphan medicinal products

BACKGROUND: Funding of orphan medicinal products (OMPs) is an increasing challenge in the European Union (EU). OBJECTIVES: To identify the different methods for public funding of OMPs in order to map the availability for rare disease patients, as well as to compare the public expenditures on OMPs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Szegedi, Márta, Zelei, Tamás, Arickx, Francis, Bucsics, Anna, Cohn-Zanchetta, Emanuelle, Fürst, Jurij, Kamusheva, Maria, Kawalec, Pawel, Petrova, Guenka, Slaby, Juraj, Stawowczyk, Ewa, Vocelka, Milan, Zechmeister-Koss, Ingrid, Kaló, Zoltán, Molnár, Mária Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219168/
https://www.ncbi.nlm.nih.gov/pubmed/30396361
http://dx.doi.org/10.1186/s13023-018-0927-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219168/
https://www.ncbi.nlm.nih.gov/pubmed/30396361
http://dx.doi.org/10.1186/s13023-018-0927-y

Ejemplares similares